APOE ε4 allele
E115305
The APOE ε4 allele is a genetic variant of the apolipoprotein E gene that significantly increases an individual's susceptibility to late-onset Alzheimer's disease.
All labels observed (2)
| Label | Occurrences |
|---|---|
| APOE ε4 allele canonical | 2 |
| apolipoprotein E4 isoform | 1 |
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf |
allele
ⓘ
genetic variant ⓘ risk factor ⓘ |
| associatedWith |
atherosclerosis
ⓘ
cerebral amyloid angiopathy ⓘ cognitive decline ⓘ coronary artery disease ⓘ earlier age of onset of Alzheimer’s disease ⓘ hippocampal atrophy ⓘ increased amyloid-β deposition ⓘ increased low-density lipoprotein cholesterol ⓘ increased risk of Alzheimer’s disease ⓘ increased risk of cerebral microbleeds ⓘ increased risk of dementia with Lewy bodies ⓘ increased risk of intracerebral hemorrhage ⓘ increased risk of ischemic stroke ⓘ increased total cholesterol ⓘ late-onset Alzheimer’s disease ⓘ mild cognitive impairment ⓘ poorer memory performance in aging ⓘ poorer outcome after subarachnoid hemorrhage ⓘ poorer outcome after traumatic brain injury ⓘ sporadic Alzheimer’s disease ⓘ |
| definedBy | specific SNP combination at rs429358 and rs7412 ⓘ |
| differsFrom |
APOE ε2 allele
ⓘ
APOE ε3 allele ⓘ |
| encodes |
APOE ε4 allele
self-linksurface differs
ⓘ
surface form:
apolipoprotein E4 isoform
|
| hasAminoAcidChange | arginine at positions 112 and 158 of apolipoprotein E ⓘ |
| hasEffect |
increases risk of late-onset Alzheimer’s disease in a dose-dependent manner
ⓘ
lowers average age at onset of Alzheimer’s disease ⓘ one copy increases Alzheimer’s disease risk compared to non-carriers ⓘ two copies greatly increase Alzheimer’s disease risk compared to non-carriers ⓘ |
| hasFrequency | varies by population ⓘ |
| hasHigherFrequencyIn | people of Northern European ancestry ⓘ |
| hasInheritancePattern |
autosomal
ⓘ
codominant ⓘ |
| hasLowerFrequencyIn |
East Asia
ⓘ
surface form:
East Asian populations
some African populations ⓘ |
| hasRiskMagnitude | moderate to high for late-onset Alzheimer’s disease ⓘ |
| influences |
amyloid-β aggregation
ⓘ
amyloid-β clearance ⓘ lipid transport in the brain ⓘ neuroinflammation ⓘ synaptic function ⓘ tau pathology progression ⓘ |
| isDetectedBy | genetic testing ⓘ |
| locatedIn | APOE gene locus 19q13.32 ⓘ |
| locatedOn | chromosome 19 ⓘ |
| modifies | response to Alzheimer’s disease pathology ⓘ |
| partOf | APOE gene ⓘ |
| usedIn | Alzheimer’s disease risk stratification in research settings ⓘ |
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
apolipoprotein E4 isoform
ARIA-H (amyloid-related imaging abnormalities with microhemorrhages and hemosiderin deposits)
→
riskFactor
→
APOE ε4 allele
ⓘ
subject surface form:
ARIA-H